Steph & Co’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.3K Sell
108
-172
-61% -$15.1K ﹤0.01% 262
2026
Q1
$25.3K Buy
280
+11
+4% +$1.01K 0.01% 236
2025
Q4
$24.2K Buy
269
+131
+95% +$12.4K 0.01% 246
2025
Q3
$13.6K Buy
138
+11
+9% +$1.09K ﹤0.01% 283
2025
Q2
$11.6K Hold
127
﹤0.01% 267
2025
Q1
$14.4K Buy
127
+28
+28% +$3K 0.01% 224
2024
Q4
$10.5K Sell
99
-87
-47% -$9.34K ﹤0.01% 245
2024
Q3
$20.1K Buy
186
+45
+32% +$4.91K 0.01% 221
2024
Q2
$15.3K Buy
141
+11
+8% +$1.3K 0.01% 227
2024
Q1
$17.2K Buy
+130
New +$16.2K 0.01% 231
2023
Q2
Sell
-27
Closed -$3.49K 246
2023
Q1
$3.49K Hold
27
﹤0.01% 229
2022
Q4
$3K Hold
27
﹤0.01% 239
2022
Q3
$3K Hold
27
﹤0.01% 225
2022
Q2
$3K Hold
27
﹤0.01% 227
2022
Q1
$3K Sell
27
-1
-4% -$121 ﹤0.01% 288
2021
Q4
$3K Hold
28
﹤0.01% 297
2021
Q3
$4K Hold
28
﹤0.01% 264
2021
Q2
$4K Hold
28
﹤0.01% 232
2021
Q1
$4K Hold
28
﹤0.01% 230
2020
Q4
$4K Hold
28
﹤0.01% 229
2020
Q3
$4K Hold
28
﹤0.01% 220
2020
Q2
$3K Hold
28
﹤0.01% 232
2020
Q1
$3K Hold
28
﹤0.01% 242
2019
Q4
$4K Buy
+28
New +$3.87K ﹤0.01% 249

Other funds holding ZBH

Steph & Co's ZBH Position: Q2 2026 in Review

Steph & Co reduced its Zimmer Biomet (ZBH) stake by 61% in Q2 2026, selling an estimated $15.1K and leaving 108 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Steph & Co first reported a position in ZBH in Q4 2019 and has held it in 24 quarters since. The position peaked at $25.3K in Q1 2026. 113 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Steph & Co held 108 shares of Zimmer Biomet worth $9.3K as of Q2 2026.
  • Steph & Co sold 172 Zimmer Biomet shares in Q2 2026, an estimated $15.1K.
  • Zimmer Biomet made up ﹤0.01% of Steph & Co's portfolio in Q2 2026, its #262 holding.
  • Steph & Co first reported a position in Zimmer Biomet in Q4 2019 and has held it in 24 quarters since.
  • Steph & Co's Zimmer Biomet position peaked at $25.3K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.